Aya Gold & Silver Inc (0HE1)

The 2013–2015 Inflection Point: During this specific window, the global video distribution landscape was in a state of high transition. The industry was moving toward 4K and specialized high-fidelity streaming, but the hardware decoding ecosystems for standard formats were not yet entirely locked do

Just get us our FCNCA stock and we will figure out what too do with it SELL It or HOLD IT

And hw many of those before were prepped and submitted by Smith of Hogan Lovells!?.....oh right the ans is zero! Pretty sure he knows a whole lot more abt what the FDA wants compared to MK just winging it in the past.

Of course they could, but here's the quote from Beartrap:

"IMHO, the real question now is will Dr. Bosch release the decision on the MAA at this presentation?"

Introductory Macroeconomic Overview
When WE published our preliminary reviews of NVIDIA Corporation (Ticker: NVDA) in April and May 2026, our primary objective was to expose the superficiality of the consensus market narrative. Today, in late June 2026, as market euphoria is mechanically sust

How many shares did you top off in the 70s and 80's?

Must be quite a bit according to your posting history

All the PLD data in the world isn’t going to tell them why L worked on a small number of patients. LP was likely told to figure that out first then resume trials. That’s also why LL became a SA. Without that information, another trial, and combined with reasonable cost, UK Marketing approval at th

Same here, and what a great price! He sure seems like it.

they were accumulated over severall weeks by the market makers

Calling this 'fear-based' is a convenient way to dismiss a forensic balance sheet analysis. You’re trading off consensus narratives; I’m trading off what’s actually recorded in the filings. Let’s address your 'scrutiny':

On Receivables & Cash Flow: You claim DSO is 'stable' and 'no ve

Right, and Ern and the 70 other AD patients you claim are still alive and taking Blarcamesine every day even though the compassionate use program ended in 2024. Are these folks mixing their own batches of Blarcamesine in Ern’s basement?

brazen22,

Thank you for supplying that direct quote. Again, “authorities” is plural so the warning is warranted because FDA only “accepts” the SAP hence the caution that one or more of those “authorities” may not grant product APPROVAL based on that approach. This statement covers t

Could go on forever but I seriously doubt that it will

DA BOYZ which have enough money to seriously stir the POT want their money as well

Anyone.....has the company ever indicated they're looking at uplisting?

I have said on multiple occasions here that IF none OF THE dates PRODUCE ANYTHING, then I will wait for closing of the "R" before I make any decisions as to if anything is or IS NOT coming back.
CBOA( indicated that we MAY VERY WELL HAVE TO WAIT for the "R" to be lifted before anything takes

Apologies. Do you find Hoffman is not doing as well as micky mouse mulholland and sidekick weed/wine.??

The 3 rounds of financing were linked .
So for #1-- Did you not like the Yorkville deal because of there are no warrants, derivatives, or other share classes asso

Scientific analysis with patient level data is not a distraction. If you can’t follow, spend that upcoming half hour on your rowing machine.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177739827

Pick 4 Contest #24 Contest Week 6 Results In

Hope everyone enjoys the stats and has fun in the contest. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-24-50633

I bet that's true of the others that recently showed up as well. They'll all disappear at the same time too. I'm sure it's coincidence.

Pick 4 Contest #24 Contest Week 6 Results In

Hope everyone enjoys the stats and has fun in the contest. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-24-50633

I agree. The sooner the better. Also while they are at it, they should replace the VP of IR who came from Antares. In over 30 years of experience as an investor in biopharma, I have not seen one with such poor performance.

Have to agree with you on that one. Its very possible IDE approval may not have a huge effect on the PPS, but....if the right peeps hop onboard it could get real crazy on news. I guess w'ell see soon enuf.

He does it as a public service. Purely voluntary! Except for the free shares.

The Tokai "335" caught my eye;
that first guy was a guitar player, imo.